BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36626930)

  • 21. Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation.
    Kosmidou I; Liu Y; Alu MC; Liu M; Madhavan M; Chakravarty T; Makkar R; Thourani VH; Biviano A; Kodali S; Leon MB
    JACC Cardiovasc Interv; 2019 Aug; 12(16):1580-1589. PubMed ID: 31439338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention.
    Paciaroni M; Agnelli G; Caso V; Silvestrelli G; Seiffge DJ; Engelter S; De Marchis GM; Polymeris A; Zedde ML; Yaghi S; Michel P; Eskandari A; Antonenko K; Sohn SI; Cappellari M; Tassinari T; Tassi R; Masotti L; Katsanos AH; Giannopoulos S; Acciarresi M; Alberti A; Venti M; Mosconi MG; Vedovati MC; Pierini P; Giustozzi M; Lotti EM; Ntaios G; Kargiotis O; Monaco S; Lochner P; Bandini F; Liantinioti C; Palaiodimou L; Abdul-Rahim AH; Lees K; Mancuso M; Pantoni L; Rosa S; Bertora P; Galliazzo S; Ageno W; Toso E; Angelini F; Chiti A; Orlandi G; Denti L; Flomin Y; Marcheselli S; Mumoli N; Rimoldi A; Verrengia E; Schirinzi E; Del Sette M; Papamichalis P; Komnos A; Popovic N; Zarkov M; Rocco A; Diomedi M; Giorli E; Ciccone A; Mac Grory BC; Furie KL; Bonetti B; Saia V; Guideri F; Acampa M; Martini G; Grifoni E; Padroni M; Karagkiozi E; Perlepe K; Makaritsis K; Mannino M; Maccarrone M; Ulivi L; Giannini N; Ferrari E; Pezzini A; Doronin B; Volodina V; Baldi A; D'Amore C; Deleu D; Corea F; Putaala J; Santalucia P; Nardi K; Risitano A; Toni D; Tsivgoulis G
    Stroke; 2019 Aug; 50(8):2168-2174. PubMed ID: 31234756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke.
    Siu CW; Jim MH; Ho HH; Miu R; Lee SW; Lau CP; Tse HF
    Chest; 2007 Jul; 132(1):44-9. PubMed ID: 17400657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation.
    Xian Y; O'Brien EC; Liang L; Xu H; Schwamm LH; Fonarow GC; Bhatt DL; Smith EE; Olson DM; Maisch L; Hannah D; Lindholm B; Lytle BL; Pencina MJ; Hernandez AF; Peterson ED
    JAMA; 2017 Mar; 317(10):1057-1067. PubMed ID: 28291892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
    Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Atrial Fibrillation During Acute Myocardial Infarction May Not Be an Indication for Long-Term Anticoagulation.
    Axelrod M; Gilutz H; Plakht Y; Greenberg D; Novack L
    Angiology; 2020 Jul; 71(6):559-566. PubMed ID: 32103687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006.
    Béjot Y; Ben Salem D; Osseby GV; Couvreur G; Durier J; Marie C; Cottin Y; Moreau T; Giroud M
    Neurology; 2009 Jan; 72(4):346-53. PubMed ID: 19171832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database.
    van den Ham HA; Klungel OH; Singer DE; Leufkens HG; van Staa TP
    J Am Coll Cardiol; 2015 Oct; 66(17):1851-9. PubMed ID: 26493655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.
    Vora AN; Dai D; Matsuoka R; Harrison JK; Hughes GC; Sherwood MW; Piccini JP; Bhardwaj B; Lopes RD; Cohen D; Holmes DR; Thourani VH; Peterson E; Kirtane A; Kapadia S; Vemulapalli S
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1746-1756. PubMed ID: 30190063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation.
    Fox KAA; Virdone S; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Kayani G; Oto A; Misselwitz F; Piccini JP; Dalgaard F; Turpie AGG; Verheugt FWA; Kakkar AK;
    Eur Heart J Qual Care Clin Outcomes; 2022 Mar; 8(2):214-227. PubMed ID: 33892489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study.
    Lamberts M; Lip GY; Ruwald MH; Hansen ML; Özcan C; Kristensen SL; Køber L; Torp-Pedersen C; Gislason GH
    J Am Coll Cardiol; 2014 Jun; 63(24):2689-98. PubMed ID: 24794118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.
    Huisman MV; Rothman KJ; Paquette M; Teutsch C; Diener HC; Dubner SJ; Halperin JL; Ma CS; Zint K; Elsaesser A; Bartels DB; Lip GY;
    J Am Coll Cardiol; 2017 Feb; 69(7):777-785. PubMed ID: 28209218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany.
    Wicke FS; Schaller MA; Karymova K; Beyer M; Müller BS
    BMC Cardiovasc Disord; 2019 Apr; 19(1):94. PubMed ID: 31014253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
    Golive A; May HT; Bair TL; Jacobs V; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
    Am J Cardiol; 2017 Jul; 120(1):75-82. PubMed ID: 28483209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA2DS2-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially 'Low-Risk' Patients.
    Chao TF; Liao JN; Tuan TC; Lin YJ; Chang SL; Lo LW; Hu YF; Chung FP; Chen TJ; Lip GYH; Chen SA
    Thromb Haemost; 2019 Jul; 119(7):1162-1170. PubMed ID: 30900222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of cardiovascular events and incident atrial fibrillation in patients without prior atrial fibrillation: Implications for expanding the indications for anticoagulation.
    Yao X; Gersh BJ; Sangaralingham LR; Shah ND; Noseworthy PA
    Am Heart J; 2018 May; 199():137-143. PubMed ID: 29754652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study.
    Hsu JC; Huang YT; Lin LY
    Aging (Albany NY); 2020 Nov; 12(23):24219-24227. PubMed ID: 33226371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.